Hans van den Heuvel

7 The demographic data of both groups are shown in Table 1. Obstetric characteristics of relevance to this topic are indicated for the interviewees and questionnaire participants (see Table 1). After analysis of the data from the interviews and questionnaires, we identified 4 themes. Of these, 2 themes were related to the mHealth technology itself (themes 1 and 2), and 2 themes were related to the interaction with and use of the technology (themes 3 and 4). Table 1. Patient characteristics. Questionnaires n=52 Interviews n=11 Maternal age (years), mean (SD) 34.4 (4.1) 34.2 (2.5) BMI (kg/m2), mean (SD) 24.9 (4.6) 23.9 (2.5) Ethnicity, n (%) Caucasian 47 (90.4) 11 (100) Afro-Caribbean 0 (0) 0 (0) Mediterranean 3 (5.8) 0 (0) Other 2 (3.8) 0 (0) Level of education, n (%) Primary school 1 (1.9) 0 (0) Secondary school 4 (7.7) 0 (0) Middle-level applied education 14 (26.9) 3 (27.3) Higher-level applied education 17 (32.7) 6 (54.5) Scientific education (university) 13 (25.0) 2 (18.2) Unknown 3 (5.8) 0 (0) Nulliparous, n (%) 19 (36.5) 2 (18.2) HDP prior pregnancy, n (%) None 14 (26.9) 3 (27.3) Chronic hypertension 1 (1.9) 1 (9.1) Gestational hypertension 5 (9.6) 2 (18.2) Preeclampsia/HELLP 13 (25.0) 3 (27.3) Not applicable (nulliparous) 19 (36.5) 2 (18.2) Initial diagnosis at start of SAFE@home study Preeclampsia in prior pregnancy 10 (19.2) 2 (18.2) Chronic hypertension 17 (32.7) 5 (45.5) Cardiac disease 17 (32.7) 3 (27.3) Renal disease 8 (15.4) 1 (9.1) HDP current pregnancy, n (%) None 23 (44.2) 2 (18.2) Chronic hypertension 14 (26.9) 3 (27.3) Gestational hypertension 6 (11.5) 2 (18.2) Preeclampsia 9 (17.3) 4 (36.4) Legend: HDP: hypertensive disorders of pregnancy, HELLP: hemolysis, elevated liver enzymes, low platelet count. USER EXPERIENCES OF BLOOD PRESSURE TELEMONITORING IN PREGNANCY 107